The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity

Aaron S Meyer1, Annelien J M Zweemer1, Douglas A Lauffenburger1

  • 1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA 02139 ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge MA 02139.

Cell Systems
|August 4, 2015
PubMed

Insights

The AXL receptor tyrosine kinase (RTK) plays a role in inflammation and cancer. This study reveals AXL senses ligand concentration through reaction-diffusion, offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Systems Biology

Background:

  • AXL receptor tyrosine kinase (RTK) is implicated in inflammation and cancer progression.
  • AXL overexpression contributes to drug resistance and tumor dissemination in solid tumors.
  • Existing knowledge on Gas6-AXL signaling lacks mechanistic detail regarding activation.

Purpose of the Study:

  • To elucidate the detailed, mechanistic picture of AXL activation.
  • To understand how ligand-receptor interactions influence AXL signaling.
  • To provide insights for designing targeted AXL therapeutics.

Main Methods:

  • Integration of quantitative experimental data.
  • Application of mathematical modeling approaches.
  • Analysis of reaction-diffusion interactions.

Main Results:

  • AXL functions by sensing local spatial heterogeneity in ligand concentration.
  • This sensing mechanism is driven by complex reaction-diffusion interactions.
  • AXL activation mechanism differs from other receptor tyrosine kinase families.

Conclusions:

  • AXL's distinct activation mechanism is crucial for its physiological roles in inflammation.
  • Understanding AXL's unique signaling provides a vital insight for developing targeted therapies.
  • This research paves the way for novel AXL-targeted therapeutic interventions.

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
12.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.8K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.4K